about
Enhanced levels of Hsulf-1 interfere with heparin-binding growth factor signaling in pancreatic cancer.ALDH isozymes downregulation affects cell growth, cell motility and gene expression in lung cancer cellsGlypican-1 is frequently overexpressed in human gliomas and enhances FGF-2 signaling in glioma cellsGlobal gene expression profiling of cells overexpressing SMC3.Genetic variants and risk of lung cancer in never smokers: a genome-wide association studyCell-surface heparan sulfate proteoglycans potentiate chordin antagonism of bone morphogenetic protein signaling and are necessary for cellular uptake of chordinNitric oxide-dependent processing of heparan sulfate in recycling S-nitrosylated glypican-1 takes place in caveolin-1-containing endosomes.APRIL is overexpressed in cancer: link with tumor progressionFirst reported case of Simpson-Golabi-Behmel syndrome in a female fetus diagnosed prenatally with chromosomal microarrayAltering Glypican-1 levels modulates canonical Wnt signaling during trigeminal placode developmentDual transcriptomics of virus-host interactions: comparing two Pacific oyster families presenting contrasted susceptibility to ostreid herpesvirus 1.Expression profiling of a human cell line model of prostatic cancer reveals a direct involvement of interferon signaling in prostate tumor progressionSuppression of liver regeneration and hepatocyte proliferation in hepatocyte-targeted glypican 3 transgenic mice.Molecular diversity of heparan sulfate.Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia.Polymorphisms in the SULF1 gene are associated with early age of onset and survival of ovarian cancer.Glypican-3: a new target for cancer immunotherapy.Chondrodysplasias due to proteoglycan defects.Imaging of hepatocellular carcinoma patient-derived xenografts using ⁸⁹Zr-labeled anti-glypican-3 monoclonal antibody.Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers.Hepatocellular recurrence after orthotopic liver transplantation: Is combination of α-fetoprotein and glypican-3 a reliable marker?: Hepatocellular recurrence after orthotopic liver trasplantation.Novel perspective: focusing on the X chromosome in reproductive cancers.Glypican Gene GPC5 Participates in the Behavioral Response to Ethanol: Evidence from Humans, Mice, and Fruit FliesThe proteoglycan repertoire of lymphoid cellsGlypican-1 modulates the angiogenic and metastatic potential of human and mouse cancer cells.Role of heparan sulfate as a tissue-specific regulator of FGF-4 and FGF receptor recognitionStructural remodeling of proteoglycans upon retinoic acid-induced differentiation of NCCIT cells.Identification of an H2-Kb or H2-Db restricted and glypican-3-derived cytotoxic T-lymphocyte epitope peptide.Methylation analysis of the glypican 3 gene in embryonal tumours.Tumor-stromal interactions in pancreatic cancerProteoglycans in cancer biology, tumour microenvironment and angiogenesis.Critical analysis of the potential of targeting GPC3 in hepatocellular carcinoma.Fine-tuning of cell signaling by glypicans.Mutations in the heparan-sulfate proteoglycan glypican 6 (GPC6) impair endochondral ossification and cause recessive omodysplasia.Investigation of the role of glypican 3 in liver regeneration and hepatocyte proliferation.3-M syndrome: a growth disorder associated with IGF2 silencing.Expression profile of microRNAs in c-Myc induced mouse mammary tumors.The association of arylendosulfatase 1 (SULF1) gene polymorphism with recurrent miscarriage.Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma.
P2860
Q24523684-B4D9D329-2D60-49FA-920D-CA0B9227ED1AQ24569826-297A7695-8AFD-466D-81A0-3F84BB24F674Q24674858-39E62D7E-0381-4010-9F8D-2A170521DD16Q24814467-0687E401-9358-486F-8C98-8E622E7920BFQ28383607-EBB00DCA-2DD2-48AE-8B84-EA9A4E1FE705Q28512603-F7230B17-0E77-4DC4-87D9-4330169CAA6EQ31109060-90BE174E-69ED-4BCE-8853-E8F6626155E8Q33418752-30D35DF7-084F-4AEE-A941-5CD097E91103Q33625722-15B2D0FB-0D01-422A-A826-D30C3BF05832Q33849654-3F698727-8724-4C29-962A-7AA0CC4D6BDCQ33953566-C2FE0080-3C0A-415B-A1EA-0231E9D57469Q34014610-A00915D0-A37C-4C22-94E0-E3D1C4A3110CQ34116157-C750C131-56F4-46B9-B47F-4A07A6C35D4FQ34310374-73F8592D-34D6-46DD-BD9C-66994165C0F0Q34396332-FE727403-49FD-4F40-BAB7-DEE52DF2E141Q34515500-0A71ACB7-447C-4092-AD79-3B6B419CDBB5Q34543102-118BCCCF-7B0F-4681-9027-88C59D8C76A4Q34664372-943DF31E-7B73-4325-80DF-CBC6AA4DF2D2Q35187951-4DC61956-F05D-4321-A923-A77095D3B2F5Q35345680-4FCEE843-5C3D-4DD5-ADF6-85BBE5182B51Q35507576-C4A16C64-4BC5-4776-8EF3-E50DE4D003F8Q35553879-A1E3045D-DA3B-4B45-874D-65F2BDBB954FQ35746864-EF5133C9-1329-4331-B0D2-552CA0274C70Q36208202-3FE3136F-CEDF-499B-989C-FDBB1B59E789Q36227239-B223D5FC-E98C-4DD3-86D2-9FFEA01DC679Q36294136-E5E772E5-3E6E-4298-A477-8159B9F7D626Q36565975-8E799165-2144-4F49-AF02-46ACE3248A9BQ36684407-541F3109-65F4-4896-A995-6076A35ABB3CQ36694947-7DEC76F6-8C0B-48D7-B3C0-319A742C4E2FQ36784603-2D76FAD6-FF5C-4D98-82BD-6FD0D70F486FQ36787608-E26B50D0-266B-4E11-896F-5A9BE569D895Q37031710-255FFA5B-1456-41B0-B22B-97F14D7AA9BAQ37035025-0D0AD519-274C-4518-871F-295EF93BF0C3Q37223955-9E6EE691-8AF8-4299-8741-640492928660Q37278475-47298FB0-AC75-4719-BAB7-17DB7CE2D7C6Q37358224-59DA55EE-68FD-4570-A968-4F800906234EQ37439539-D0F5BC07-BBA7-48FC-BE39-1AC709CE830FQ37601077-F673E83E-2E58-40B3-BD7D-97CBF039E31EQ37645001-263E417B-4767-4788-84AC-8AAF8F4F4B1DQ37688462-FF11F483-A44F-4360-8FC1-51D2DA2237A3
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Glypicans in growth control and cancer
@ast
Glypicans in growth control and cancer
@en
Glypicans in growth control and cancer
@nl
type
label
Glypicans in growth control and cancer
@ast
Glypicans in growth control and cancer
@en
Glypicans in growth control and cancer
@nl
prefLabel
Glypicans in growth control and cancer
@ast
Glypicans in growth control and cancer
@en
Glypicans in growth control and cancer
@nl
P356
P1433
P1476
Glypicans in growth control and cancer
@en
P2093
P304
P356
10.1093/GLYCOB/11.3.19R
P407
P577
2001-03-01T00:00:00Z